Triple
T9812300
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | aflibercept |
E238303
|
entity |
| Predicate | hasTradeName |
P24555
|
FINISHED |
| Object |
Zaltrap
Zaltrap is a cancer medication (brand name for aflibercept) used primarily in combination chemotherapy to treat metastatic colorectal cancer by inhibiting vascular endothelial growth factor (VEGF).
|
E823215
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69ca84defac48190abc1148804f184c1 |
elicitation | completed |
| NER | batch_69cdb222ba788190a9085272a3de7852 |
ner | completed |
| NED1 | batch_69d1cc63c450819091e57030a48e7d88 |
ned_source_triple | completed |
| NED2 | batch_69d1cd5d1670819085c58ff8889318af |
ned_description | completed |
| NEDg | batch_69d1cce3d9d481909eaf7278dfe20955 |
nedg | completed |
Created at: March 30, 2026, 8:30 p.m.